Personalized Circadian mHealth for Shift Work Sleep Disorder
(SAIL Trial)
Trial Summary
What is the purpose of this trial?
The goal of this project is to establish the evidence base for equitable accessibility and implementation of the precision sleep medicine mobile application, SHIFT.
Will I have to stop taking my current medications?
Yes, if you are currently using medications that affect sleep-wake functioning, you will need to stop taking them to participate in this trial.
What data supports the effectiveness of the treatment SHIFT for Shift Work Sleep Disorder?
Research shows that personalized sleep-wake management tools, like mobile apps, can improve sleep and alertness for shift workers by providing tailored sleep schedules. These tools help align sleep patterns with the body's natural rhythms, reducing daytime sleepiness and improving overall well-being.12345
Is the Personalized Circadian mHealth treatment for Shift Work Sleep Disorder safe for humans?
How does the treatment SHIFT differ from other treatments for Shift Work Sleep Disorder?
Eligibility Criteria
This trial is for night shift workers who often get less than 7 hours of sleep during the day, can stick to a set sleep schedule after work, and work shifts starting between 6 PM and 2 AM. Participants must be willing to use the SHIFT app and follow its light exposure advice, work at least four night shifts per month, and have certain scores indicating sleepiness or insomnia. It's not for those with bipolar disorder, changing shift schedules, pregnancy, substance issues, on sleep-impacting meds or with other serious sleep disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants in the SHIFT App condition receive an access code to download the app and conduct an orientation. They then enter four weeks of study-directed use of SHIFT.
Self-directed Use
Participants continue with self-directed use of the SHIFT app after the initial treatment phase.
Booster Session
Participants complete a booster session with two additional weeks of study-directed use, followed by continued self-directed use.
Follow-up
Participants are monitored for outcomes such as work productivity, satisfaction, and turnover at the 8-month follow-up.
Treatment Details
Interventions
- SHIFT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor